Among patients with stable angina or an acute coronary syndrome, an iFR-guided revascularization strategy was noninferior to an FFR-guided revascularization strategy with respect to the rate of major adverse cardiac events at 12 months. (Funded by Philips Volcano; iFR SWEDEHEART ClinicalTrials.gov number, NCT02166736 .).
Building similarity graph...
Analyzing shared references across papers
Loading...
Matthias Götberg
Interventional Cardiology
Evald Høj Christiansen
Interventional Cardiology
Ingibjörg Jóna Guðmundsdóttir
Interventional / Structural Cardiology
New England Journal of Medicine
Karolinska Institutet
Lund University
Uppsala University
Building similarity graph...
Analyzing shared references across papers
Loading...
Götberg et al. (Sat,) studied this question.
synapsesocial.com/papers/6970ddc8cfea4c1fcf6a58d4 — DOI: https://doi.org/10.1056/nejmoa1616540